In the U.S. alone, over 133 million people live with chronic diseases, many of which require regular infusions to treat conditions like cancer, immunological disorders, and rare blood diseases. These treatments are critical — but often burdensome. Administered through intravenous (IV) infusions in clinics or hospitals, they demand time, travel, and a dependence on healthcare infrastructure that many patients find physically and emotionally taxing. As these therapies expand in scale and complexity, so does the need for drug delivery systems that work with people's lives.